Learn More
Medchemexpress LLC Tetrabenazine-d6 | 1392826-25-3 | ≥99.0% | 25 MG

Supplier: Medchemexpress LLC 25MGHYB0590S
Tetrabenazine-d6 (Deutetrabenazine) is a deuterium-labeled Tetrabenazine, the first deuterium approved worldwide for the research of Huntington's disease or other hyperkinetic movement disorders.
- Can be used as a tracer.
- Can be used as an internal standard for quantitative analysis by NMR, GC-MS, or LC-MS.
- Extends the half-life in vivo.
- Improves oral bioavailability.
- Improves metabolic characteristics, potentially reducing toxic or reactive metabolites.
- Improves drug safety by reducing or eliminating adverse side effects.
- Preserves therapeutic properties, retaining similar biochemical potency and selectivity to hydrogen analogs.
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.